𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Toxicity of photodynamic therapy with photofrin in the normal rat brain

✍ Scribed by Ying Ji; Dr. Stephen K. Powers; J. Tony Brown; Diana Walstad; Lloyd Maliner


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
1007 KB
Volume
14
Category
Article
ISSN
0196-8092

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The widespread acceptance of photodynamic therapy (PDT), a potential adjuvant brain tumor therapy under clinical evaluation since 1980, has been partially restrained by its potential toxicity toward normal brain tissue. This study examined PDT‐produced injury of normal rat brain as a function of photosensitizer dose. Brain injury was characterized by correlating measurements of the area of cerebral edema using T2‐weighted magnetic resonance images, measurement of brain water content at the lesion site, microscopic examination of histological sections through the PDT lesion, and by evaluation of the area of blood brain barrier (BBB) disruption using computerized morphometric analysis of the region of Evans blue (EB) dye‐labelled albumin extravasation. Monochromatic red light (630 nm) was delivered intracere‐brally using a 5‐mm‐long cylindrical, diffusion‐tip optical fiber at a constant energy dose of 15 joules.

A Photofrin dose of 2 mg/kg of body weight produced a transient breakdown in the blood brain barrier around the site of the implanted optical fiber demonstrated by magnetic resonance imaging (MRI), extravasation of EB dye and pallor on hematoxylin and eosin‐stained microscopic tissue sections. A much larger area of BBB disruption was seen at a dose of 4 mg/kg of Photofrin, and this drug dose resulted in significant permanent brain injury. In this model, a Photofrin dose of 4 mg/kg body weight is not tolerated by the normal brain. © 1994 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Intraperitoneal photodynamic therapy in
✍ Ruth B. Veenhuizen; Marjan C. Ruevekamp-Helmers; Theo J. M. Helmerhorst; Peter K 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 980 KB

## Abstract Toxicity studies for intraperitoneal photodynamic therapy (IPPDT) were performed in Wag/RijA rats, using specially designed light delivery blocks for proper light distribution and light dosimetry. A recently developed photosensitizer mesotetrahydroxyphenylchlorin (mTHPC), excited at 652

Photodynamic therapy using Photofrin in
✍ Jiang, Feng; Lilge, Lothar; Belcuig, Marie; Singh, Gurmit; Grenier, Joseph; Li, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Background and Objective : The reactive oxygen mechanisms associated with cell damage after photodynamic therapy (PDT) may be exploited to enhance tumor destruction. Pharmacological reduction of glutathione (GSH), an inhibitor of reactive oxygen species, can be induced by administration of buth

Photodynamic therapy of U87 human glioma
✍ Jiang, Feng; Lilge, Lothar; Grenier, Joseph; Li, Yi; Wilson, Mark D.; Chopp, Mic 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

## Background and objective: Liposomes as photosensitizer carriers may enhance the photodynamic effect on tumors. ## Study design/materials and methods: To test this hypothesis, we treated u87 human glioma in rat brain with photodynamic therapy (pdt) using photofrin encapsulated in a liposome car

Experimental determination of threshold
✍ J. Ferreira; L.T. Moriyama; C. Kurachi; C. Sibata; O. Castro e Silva Jr.; S. Zuc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Using normal rat liver we investigated the depth of necrosis induced by photodynamic therapy when different light doses and photosensitizer (Photogem®) concentrations. All experiments were done with a fluence rate of 250 mW/cm^2^. Photosensitizer concentration was varied from 1.0, 1.5, 2.0, and 5.0